Tier 3 · Filer Universe

Xilio Therapeutics, Inc.

XLO · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$9.00
+0.00%
Coverage
Tier 3
Tier 3 · Filer Universe
SEC CIK
0001840233
Liquidity rank
#5639
Observed dollar volume

Tier 3 is a directory treatment. It does not imply options, analyst estimates, or complete company-facts coverage. Missing fields stay missing.

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenue$43.77M2025-12-310001193125-26-118550
Annual diluted EPS-4.192025-12-310001193125-26-118550
Quarterly revenue$18.69M2026-06-300001193125-26-345759
Quarterly diluted EPS-0.332026-06-300001193125-26-345759

SEC EDGAR Frames batch generated 2026-09-08T00:39:23.565Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNasdaqBMY · Tier 1 peerDHR · Tier 1 peerMRK · Tier 1 peerPFE · Tier 1 peer

Provenance

IdentitySEC company tickers and Nasdaq Symbol Directory
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames